RNXT
RenovoRx Inc
1.60$
+1.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | 47.7% | 36.0% | 19.9% | 11.8% | 14.9% | 15.7% | 15.6% | |
| – | – | – | – | – | – | 52.3% | 64.0% | 80.1% | 88.2% | 85.1% | 84.3% | 84.4% | |
| – | – | – | – | – | 3,665.1% | 833.5% | 337.9% | 633.5% | 630.7% | 218.1% | 132.0% | 284.1% | |
| – | – | – | – | – | 2,555.8% | 797.5% | 360.7% | 649.6% | 660.1% | 483.1% | 320.7% | 452.1% | |
| – | – | – | – | – | 6,220.9% | 1,631.0% | 698.6% | 1,283.1% | 1,568.5% | 701.2% | 437.0% | 762.4% | |
| – | – | – | – | – | -6,120.9% | -1,578.7% | -634.6% | -1,203.0% | -1,480.3% | -616.2% | -352.7% | -678.0% | |
| – | – | – | – | – | -6,693.0% | -1,228.4% | -686.0% | -1,094.7% | -1,236.1% | -625.4% | -320.2% | -621.8% | |
| – | – | – | – | – | – | 1,256.9% | – | – | – | – | – | – | |
| – | – | – | – | – | -6,693.0% | -1,228.4% | -686.0% | -1,094.7% | -1,235.7% | -625.4% | -320.2% | -621.7% | |
| – | – | – | – | – | – | -1,227.9% | -685.8% | -1,095.1% | -1,235.7% | -625.2% | -320.2% | -621.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.